No items found.
Left chevron

Go Back

Pharmacology

Bempedoic Acid - ATP Citrate Lyase (ACL) Inhibitors Review

Bempedoic acid (Nexletol) ACL inhibitor review: mechanism, LDL cholesterol lowering, statin intolerance use, and high-yield pharmacology

Video thumbnail

To view this video, please enable marketing cookies from Cookie Preferences in the footer.

Horizontal dot pattern

ATP Citrate Lyase (ACL) Inhibitors made simple.  In this lecture from This is Why, Dr. Busti will provide you with a review of Bempedoic Acid (Nexletol), and you’ll learn how this lipid-lowering drug works, when to use it (including statin intolerance), and the key clinical pearls you need for exams and practice.

You’ll learn how to:
- What ATP citrate lyase inhibitors are and where they work in cholesterol synthesis
- Bempedoic acid mechanism of action + why it’s different from statins
- Effects on LDL cholesterol (LDL lowering drugs overview)
- Indications: hyperlipidemia, dyslipidemia, ASCVD risk reduction, statin-intolerant patients
- High-yield adverse effects, contraindications, and monitoring
- Drug interactions and counseling points you’ll actually use

The goal = make medical education easy and clinically relevant.

Chapter Table of Contents

00:00 ACL Inhibitors: What They Are + Why They Matter for LDL
02:08 Bempedoic Acid: The Only ACL Inhibitor (+ Ezetimibe Combo)
03:14 Indications: Add-On to Statins, ASCVD Prevention, HeFH
04:05 HeFH Explained: Why LDL Clearance Fails + Early ASCVD Risk
05:31 Clinical Benefit: MACE Reduction + 15–30% LDL Lowering
07:41 Mechanism Overview: Where ACL Inhibition Fits vs Statins
08:35 Bempedoic Acid Is a Prodrug: Liver Activation, Less Muscle Risk
10:01 How It Changes Lipids: LDL Targeting + Why TG/HDL Effects Differ
14:11 Cholesterol Pathway Map: ↓VLDL Output + ↑LDL Receptors
18:17 Key Safety Issue: OAT2 Competition → ↑Uric Acid & Gout Flares
19:50 Drug Interactions: Statins (Simva/Prava) + Dose Limit Rationale
21:37 Place in Therapy: Once-Daily Oral, No Major Dose Adjustments
22:37 Adverse Effects: Tendon Risk Signals, Liver/Renal Reports, Context
25:04 Monitoring: Lipid Panels + Watch for Gout/Organ Function Issues
27:10 High-Yield Recap: Indications, Mechanism, Interactions, Monitoring

If this helped you, please like, subscribe to our YouTube Channel, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications on YouTube so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#lipidloweringdrugs LDLdrugspharmacology #BempedoicAcid #nexletol #busti

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

This is why - membership

More than just access—it’s where understanding deepens.

Create a free account or log in to gain access to this content!

Dot pattern graphic

Dive Deeper

Bonus Video (ad free)

Deep Dive video thumbnail

To view this video, please enable marketing cookies.

Downloads

Lipid Lowering Pharmacology Lectures - Tables and Diagrams

Dive Deeper

Bonus Video

Downloads

Lipid Lowering Pharmacology Lectures - Tables and Diagrams